… COVID-19 cases. This seemingly contradictory observation is in fact confirmation of the
underlying immunopathogenesis in patients with critical COVID-19… outcome in COVID-19. Tissue …

… COVID19 among children, healthy adults, and weak co-morbid adults is that there might be a
good level of similarity between COVID19 … A therapeutic clinical trial might shed light on the …

… Therapeutic plasmapheresis (TP) is the … immunopathogenesis and coagulopathy induced
by SARS-CoV-2 and the potential benefits of TP as adjunctive treatment in critically COVID-19 …

… knowledge on the immunopathogenesis of GBS in the context of coronavirus disease 2019
(… in COVID-19 vaccinations, although the causal relationship between COVID-19 vaccines …

… -COVID-19 vaccines and therapeutic drugs, in order to gain control over the quick spread of
this novel coronavirus. … but may play a role in driving the immunopathogenesis of COVID-19. …

… In this article, we summarize reports on blood cytokine levels and leukocyte activation to
examine for differences in immunopathogenesis between mild and severe cases of COVID-19 …

… Therefore, understanding the precise role of inflammatory cytokines such as IL-6 is
crucial in the immunopathogenesis of COVID-19. Produced IL-6 and macrophage colony-stimulating …

… to clarify immunopathogenesis and immune response; however, new therapeutic approaches
including mesenchymal stromal cell and immune cell therapy showed inspiring results. …

… Although the immunopathogenesis of COVID-19 is not well … the immunopathogenesis of
COVID-19 and the differences between affected individuals is essential for designing therapies …

… coronavirus disease 2019 (COVID-19) involves deconvoluting the complex spectrum of
immune responses in patients with COVID-19. … acute respiratory syndrome coronavirus 2 (SARS-…